Protocol
Growth Hormone
Hexarelin + CJC-1295 Stack Protocol [2026]
Maximum GH output research with the added cardioprotective properties observed with hexarelin at lower doses.
Compounds
Hexarelin
Dose: 100 mcg
Freq: Twice daily
Recon: 5mg + 2mL BAC
Conc: 2,500 mcg/mL
Draw: 4 units (U-100)
Calculate Hexarelin dose
CJC-1295 (No DAC)
Dose: 100 mcg
Freq: Twice daily
Recon: 2mg + 2mL BAC
Conc: 1,000 mcg/mL
Draw: 10 units (U-100)
Calculate CJC-1295 (No DAC) dose
Protocol Phases
Full Protocol
Weeks 1 to 8
Hexarelin 100 mcg + CJC-1295 100 mcg twice daily: morning and before bed. Cap at 8 weeks due to hexarelin desensitization at higher doses and prolonged use.
FAQ
What makes hexarelin different from other GHRPs?
Hexarelin is the most potent GHRP by GH output per mcg. It also uniquely binds CD36 receptors in the heart, producing cardioprotective effects observed in research independent of its GH-releasing action. These cardiac effects are seen at lower doses (below 100 mcg) than the maximum GH-stimulating dose.
Why is the hexarelin cycle capped at 8 weeks?
Hexarelin produces more rapid pituitary desensitization than Ipamorelin or GHRP-2. GH response tends to diminish significantly after 8 to 12 weeks of continuous use. Cycles of 4 to 8 weeks followed by a washout period preserve receptor sensitivity.
Does hexarelin increase cortisol like GHRP-2?
Yes, hexarelin also stimulates cortisol and prolactin release, similar to GHRP-2. The effect is less pronounced at lower doses (50 mcg) but significant at 100 mcg twice daily. This is the main reason Ipamorelin is preferred for longer cleaner cycles while hexarelin is used for shorter high-output phases.
Research Notes
- Limit to 8 weeks maximum before a 4-week washout period.
- Hexarelin at 50 mcg twice daily shows cardioprotective CD36 binding with less cortisol elevation than 100 mcg. Consider lower doses if cardiac research is the primary goal.
- Fast 2 hours before each injection.
Related Protocols
For research use only. Not medical advice.